Challis GB, Stam HJ. The spontaneous regression of cancer A review of cases from 1900 to 1987. Acta Oncol (Stockholm, Sweden). 1990;29(5):545–50.

Article  CAS  Google Scholar 

Abdelrazeq AS. Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. Int J Colorectal Dis. 2007;22(7):727–36.

Article  PubMed  Google Scholar 

Utsumi T, Miyamoto S, Shimizu T, Yokogawa K, Nakanishi Y, Nikaido M, et al. Spontaneous regression of mismatch repair-deficient colorectal cancers: case series. Dig Endosc : Off J Jpn Gastroenterol Endosc Soc. 2021;33(1):190–4.

Article  Google Scholar 

Yokota T, Saito Y, Takamaru H, Sekine S, Nakajima T, Yamada M, et al. Spontaneous regression of mismatch repair-deficient colon cancer: a case series. Clin Gastroenterol Hepatol : Off Clin Pract J Am Gastroenterol Assoc. 2021;19(8):1720-2.e3.

Article  Google Scholar 

Cole WH. Efforts to explain spontaneous regression of cancer. J Surg Oncol. 1981;17(3):201–9.

Article  PubMed  CAS  Google Scholar 

Papac RJ. Spontaneous regression of cancer. Cancer Treat Rev. 1996;22(6):395–423.

Article  PubMed  CAS  Google Scholar 

Karakuchi N, Shimomura M, Toyota K, Hinoi T, Yamamoto H, Sadamoto S, et al. Spontaneous regression of transverse colon cancer with high-frequency microsatellite instability: a case report and literature review. World J Surg Oncol. 2019;17(1):19.

Article  PubMed  PubMed Central  Google Scholar 

Nishiura B, Kumamoto K, Akamoto S, Asano E, Ando Y, Suto H, et al. Spontaneous regression of advanced transverse colon cancer with remaining lymph node metastasis. Surg Case Rep. 2020;6(1):100.

Article  PubMed  PubMed Central  Google Scholar 

Bir AS, Fora AA, Levea C, Fakih MG. Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes. Anticancer Res. 2009;29(2):465–8.

PubMed  Google Scholar 

Sakamoto S, Fu K, Kobayashi O, Matsuyama S, Miyazaki A, Ogura K, et al. Spontaneous complete regression of a rectal cancer. Endoscopy. 2009;41(10):910–2.

Article  PubMed  CAS  Google Scholar 

Shimizu H, Kochi M, Kaiga T, Mihara Y, Fujii M, Takayama T. A case of spontaneous regression of advanced colon cancer. Anticancer Res. 2010;30(6):2351–3.

PubMed  Google Scholar 

Nakamura F, Sakamoto T, Nakajima T, Saito Y, Taniguchi H, Matsuda T. A case of rectal tumor in which the shape altered with regression in short period. BMC Gastroenterol. 2013;13:146.

Article  PubMed  PubMed Central  Google Scholar 

Sekiguchi M, Ito K, Matsuhashi N. Spontaneously disappearing colon cancer. Dig Endosc : Off J Jpn Gastroenterol Endosc Soc. 2013;25(1):88–9.

Article  Google Scholar 

Kihara K, Fujita S, Ohshiro T, Yamamoto S, Sekine S. Spontaneous regression of colon cancer. Jpn J Clin Oncol. 2015;45(1):111–4.

Article  PubMed  Google Scholar 

Chida K, Nakanishi K, Shomura H, Homma S, Hattori A, Kazui K, et al. Spontaneous regression of transverse colon cancer: a case report. Surg Case Rep. 2017;3(1):65.

Article  PubMed  PubMed Central  Google Scholar 

Matsuki R, Sugiyama M, Yoshiike S, Shibahara J, Kogure M, Yokoyama M, et al. Spontaneous regression of colorectal liver metastasis. Clin J Gastroenterol. 2018;11(4):263–7.

Article  PubMed  Google Scholar 

Shuttleworth PW, Ullah S, Scott M, Sabri S, Solkar M. Complete spontaneous regression of colorectal cancer: a report of two cases. Cureus. 2023;15(5):e39128.

PubMed  PubMed Central  Google Scholar 

Harata S, Takahashi H, Ando N, Kato A, Watanabe K, Yanagita T, et al. Spontaneous regression of advanced transverse colon cancer with deficient mismatch repair: a case report. Surg Case Rep. 2023;9(1):64.

Article  PubMed  PubMed Central  Google Scholar 

Zwart K, Ruigrok D, de Graaf-Bos M, Goldschmeding R, Koopman M, Bol GM. Spontaneous complete regression of colon cancer liver metastases in a lung transplant patient: a case report. Case Rep Transpl. 2023;2023:9643370.

Google Scholar 

Sahin IH, Akce M, Alese O, Shaib W, Lesinski GB, El-Rayes B, et al. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms. Br J Cancer. 2019;121(10):809–18.

Article  PubMed  PubMed Central  Google Scholar 

Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016;51:19–26.

Article  PubMed  CAS  Google Scholar 

Chen W, Frankel WL. A practical guide to biomarkers for the evaluation of colorectal cancer. Mod Pathol: Off J United States Canadian Acad Pathol, Inc. 2019;32:1–15.

Article  Google Scholar 

Fountzilas E, Kotoula V, Tikas I, Manousou K, Papadopoulou K, Poulios C, et al. Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer. Oncotarget. 2018;9(86):35623–38.

Article  PubMed  PubMed Central  Google Scholar 

Surmann EM, Voigt AY, Michel S, Bauer K, Reuschenbach M, Ferrone S, et al. Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer. Cancer Immunol Immunother : CII. 2015;64(3):357–66.

Article  PubMed  CAS  Google Scholar 

Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26(4):566–76.

Article  PubMed  CAS  Google Scholar 

Hu H, Kang L, Zhang J, Wu Z, Wang H, Huang M, et al. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2022;7(1):38–48.

Article  PubMed  CAS  Google Scholar 

Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, et al. PD-1 Blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363–76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ, et al. Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. Lancet Gastroenterol Hepatol. 2023;8(5):422–31.

Article  PubMed  CAS  Google Scholar 

Fan WX, Su F, Zhang Y, Zhang XL, Du YY, Gao YJ, et al. Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer. Biomark Res. 2024;12(1):89.

Article  PubMed  PubMed Central  Google Scholar